Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular MyopathyMartin K. Childers, Anna Buj‐Bello, Mark E. Furth et al.|Science Translational Medicine|2014Cited by 170
Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trialPerry B. Shieh, Salvador Rico, Nancy L. Kuntz et al.|The Lancet Neurology|2023Cited by 120
<i>MTM1</i> mutation associated with X-linked myotubular myopathy in Labrador RetrieversAlan H. Beggs, G. Diane Shelton, Johann Böhm et al.|Proceedings of the National Academy of Sciences|2010Cited by 116
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in DogsDavid L. Mack, Martin K. Childers, Karine Poulard et al.|Molecular Therapy|2017Cited by 109
Tissue Triage and Freezing for Models of Skeletal Muscle DiseaseHui Meng, Michael W. Lawlor, Paul M.L. Janssen et al.|Journal of Visualized Experiments|2014Cited by 98